These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 21144476

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Activation of brain histaminergic neurotransmission: a mechanism for cognitive effects of memantine in Alzheimer's disease.
    Motawaj M, Burban A, Davenas E, Arrang JM.
    J Pharmacol Exp Ther; 2011 Feb; 336(2):479-87. PubMed ID: 21057059
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo.
    Gbahou F, Davenas E, Morisset S, Arrang JM.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):945-54. PubMed ID: 20530654
    [Abstract] [Full Text] [Related]

  • 7. Recent advances in histamine H3 receptor antagonists/inverse agonists.
    Łazewska D, Kieć-Kononowicz K.
    Expert Opin Ther Pat; 2010 Sep 01; 20(9):1147-69. PubMed ID: 20716022
    [Abstract] [Full Text] [Related]

  • 8. Heterogeneity of histaminergic neurons in the tuberomammillary nucleus of the rat.
    Giannoni P, Passani MB, Nosi D, Chazot PL, Shenton FC, Medhurst AD, Munari L, Blandina P.
    Eur J Neurosci; 2009 Jun 01; 29(12):2363-74. PubMed ID: 19490084
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic potential of histamine H3 receptor antagonists in dementias.
    Chazot PL.
    Drug News Perspect; 2010 Mar 01; 23(2):99-103. PubMed ID: 20369074
    [Abstract] [Full Text] [Related]

  • 10. Histamine and schizophrenia.
    Arrang JM.
    Int Rev Neurobiol; 2007 Mar 01; 78():247-87. PubMed ID: 17349864
    [Abstract] [Full Text] [Related]

  • 11. CSF levels of the histamine metabolite tele-methylhistamine are only slightly decreased in Alzheimer's disease.
    Motawaj M, Peoc'h K, Callebert J, Arrang JM.
    J Alzheimers Dis; 2010 Mar 01; 22(3):861-71. PubMed ID: 20858978
    [Abstract] [Full Text] [Related]

  • 12. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders.
    Passani MB, Lin JS, Hancock A, Crochet S, Blandina P.
    Trends Pharmacol Sci; 2004 Dec 01; 25(12):618-25. PubMed ID: 15530639
    [Abstract] [Full Text] [Related]

  • 13. H3 receptor antagonists/inverse agonists as anti-obesity agents.
    Hancock AA.
    Curr Opin Investig Drugs; 2003 Oct 01; 4(10):1190-7. PubMed ID: 14649210
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease.
    Brioni JD, Esbenshade TA, Garrison TR, Bitner SR, Cowart MD.
    J Pharmacol Exp Ther; 2011 Jan 01; 336(1):38-46. PubMed ID: 20864505
    [Abstract] [Full Text] [Related]

  • 18. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
    Wenk GL.
    J Clin Psychiatry; 2006 Jan 01; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
    [Abstract] [Full Text] [Related]

  • 19. High constitutive activity of native H3 receptors regulates histamine neurons in brain.
    Morisset S, Rouleau A, Ligneau X, Gbahou F, Tardivel-Lacombe J, Stark H, Schunack W, Ganellin CR, Schwartz JC, Arrang JM.
    Nature; 2000 Dec 14; 408(6814):860-4. PubMed ID: 11130725
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.